Clinical trial

IL13 Signaling in Allergic Asthma

NCT05478824

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2023-02-21

PhaseN/A

Study timeline

Study start (actual)2023-02-21Date precision: day

Registry last updated2026-01-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Asthma, Allergicunresolved

Asthmaunresolved

Obesityunresolved

Interventions

Sponsors & collaborators

Duke Universitylead sponsor

Regeneron Pharmaceuticalscollaborator

Mapped research locations

DurhamNorth Carolina, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05478824 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.